ALC

#6787
Alcon Inc. Ordinary Shares
87.13
+0.88%
Setor:
Base:
Moeda do lucro:
Faixa diária
86.85
87.18
Faixa anual
71.55
99.20
Mudança diária
+0.88%
Mudança mensal
+8.83%
Mudança em 6 meses
+7.97%
Mudança anual
-5.36%
Fechamento anterior
86.37
Open
86.85
Bid
Ask
Low
86.85
High
87.18
Volume
663
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Alcon Inc

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Notícias